Ian Ihnatowycz

Founded in 1990, Acuity Investment Management, Inc. is a mutual fund manager located in Toronto, Ontario. The firm is a subsidiary of AGF Management Ltd. (Toronto: AGF-B.TO), a Toronto-based integrated, global wealth management firm. Acuity Investment Management provides discretionary investment management services to behalf of high net-worth individuals, pension funds and the Acuity family of mutual funds.

Acuity Growth & Income Trust is a is a closed-end investment trust with the investment objectives of providing holders of Units with monthly distributions, preserving capital throughout the life of the Trust and enhancing the long-term total return within the portfolio of securities. The fund was founded on December 17, 2003 and is headquartered in Toronto, Canada.

Acuity Small Cap Corp. is a closed-end investment trust. The company invests in a portfolio consisting primarily of securities of small capitalization publicly listed issuers and some private companies. It offers segregated accounts, pooled funds and mutual funds. The company was founded on June 6, 2007 and is headquartered in Toronto, Canada.

Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.

Myca Health, Inc. provides patient management solutions for physicians. The company offers software suites for electronic health records, networking, practice management, and patient health portal. The firm also offers management tools for communication, user satisfaction and new business models. The company was founded by Nathanial B. Findlay and is headquartered in Quebec, Canada.

Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada.

First Generation Capital, Inc. operates as an investment holding company. The company is headquartered in Toronto, Canada.